(19)
(11) EP 2 283 158 A1

(12)

(43) Date of publication:
16.02.2011 Bulletin 2011/07

(21) Application number: 09742134.1

(22) Date of filing: 07.05.2009
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
C12N 9/18(2006.01)
G01N 33/50(2006.01)
C12Q 1/44(2006.01)
(86) International application number:
PCT/EP2009/055561
(87) International publication number:
WO 2009/135916 (12.11.2009 Gazette 2009/46)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 07.05.2008 US 71593 P
13.11.2008 FR 0857715

(71) Applicant: Galderma Research & Development
06410 Biot (FR)

(72) Inventor:
  • RIVIER, Michel
    F-06100 Nice (FR)

(74) Representative: Allab, Myriam et al
L'OREAL D.I.P.I. 25-29 Quai Aulagnier
92665 Asnières-sur-Seine
92665 Asnières-sur-Seine (FR)

   


(54) SCREENING FOR MODULATORS OF CES1 AND/OR CES3 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA